Violation Tracker Individual Record
Company:Insys Therapeutics Inc.
Date:August 18, 2017
Offense Group:healthcare-related offenses
Primary Offense:off-label or unapproved promotion of medical products
Insys agreed to pay $4.45 million in settlement of allegations it deceptively promoted and sold its opioid painkiller for treatments not approved by the Food and Drug Administration.
Level of Government:state
Action Type:agency action
Agency:Illinois Attorney General
Civil or Criminal Case:civil
HQ Country of Parent:USA
HQ State of Parent:Arizona
Ownership Structure of Parent:publicly traded
Major Industry of Parent:pharmaceuticals
Specific Industry of Parent:pharmaceuticals
Source Notes:If an online information source is not working, check the Violation Tracker Data Sources page for an updated link.